News

Newly approved therapy could offer another option for protecting infants from RSV, a common infection that can be deadly
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...
Fierce Pharma2d
Feeling RSV heat from Merck, Sanofi lays out early supply plans for Beyfortus
One day before the potential FDA approval of a rival respiratory syncytial virus (RSV) monoclonal antibody from Merck & Co., ...
US Weekly on MSN1d
Mormon Wives’ Mikayla Brings Up Whitney’s Controversial RSV Dance Video Amid Feud: ‘It Slayed’
The Secret Lives of Mormon Wives' costars Whitney Leavitt and Mikayla Matthews have been feuding since season 1 of the hit ...
Clinical Trials Arena22h
Merck’s Enflonsia receives FDA approval for RSV prophylaxis
Merck’s Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...
Fierce Pharma2d
Merck scores FDA nod for Enflonsia, setting up RSV market battle vs. Sanofi and AstraZeneca's Beyfortus
Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...
CIDRAP2d
RSV, flu linked to 6% and 3% of kids' antibiotic prescriptions
Estimates varied from 2008 through 2018, with RSV-associated antibiotic prescribing exceeding 10% in peak RSV years and ...
WCCB Charlotte23h
New therapy approved for RSV in kids
WASHINGTON – The Food and Drug Administration has approved a new monoclonal antibody to protect infants from RSV. The ...
hMPV is likely one of the viruses making us sick this season. Here's what to know about human metapneumovirus
As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory ...